Art

J-GLOBAL ID：201302252732681209   Reference number：13A1176606

Guidelines for the Intravenous Application of Recombinant Tissue-type Plasminogen Activator (Alteplase), the Second Edition, October 2012: A Guideline From the Japan Stroke Society

組換え組織型プラスミノーゲン活性化因子(アルテプラーゼ)の静脈投与に対するガイドライン,第2版,2012年10月:日本脳卒中学会からのガイドライン

Author (17)： MINEMATSU Kazuo (Deputy Director General of the Hospital, National Cerebral and Cardiovascular Center, Suita, Osaka, JPN) ,  TOYODA Kazunori (Dep. of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, JPN) ,  HIRANO Teruyuki (Dep. of Neurology, Oita Univ. Fac. of Medicine, Yufu, Oita, JPN) ,  KIMURA Kazumi (Dep. of Stroke Medicine, Kawasaki Medical School, Kurashiki, JPN) ,  KONDO Rei (Dep. of Neurosurgery, Yamagata City Hospital Saiseikan, Yamagata, JPN) ,  MORI Etsuro (Dep. of Behavioral Neurology and Cognitive Neuroscience, Tohoku Univ., Sendai, JPN) ,  NAKAGAWARA Jyoji (Integrative Stroke Imaging Center, National Cerebral and Cardiovascular Center, Suita, Osaka, JPN) ,  SAKAI Nobuyuki (Dep. of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, JPN) ,  SHIOKAWA Yoshiaki (Dep. of Neurosurgery and Stroke Center, Kyorin Univ., Mitaka, JPN) ,  TANAHASHI Norio (Dep. of Neurology, Saitama Medical Univ. International Medical Center, Saitama, JPN) ,  YASAKA Masahiro (Dep. of Cerebrovascular Medicine and Neurology, Kyushu Medical Center, Fukuoka, JPN) ,  KATAYAMA Yasuo (Dep. of Internal Medicine (Division of Neurology, Nephrology, and Rheumatology), Nippon Medical School, Tokyo, JPN) ,  MIYAMOTO Susumu (Dep. of Neurosurgery, Kyoto Univ., Kyoto, JPN) ,  OGAWA Akira (CEO and President, Iwate Medical Univ., Morioka, JPN) ,  SASAKI Makoto (High Field Magnetic Resonance Imaging Res. Inst., Iwate Medical Univ., Morioka, JPN) ,  SUGA Sadao (Dep. of Neurosurgery, Tokyo Dental Coll. Ichikawa General Hospital, Ichikawa Japan) ,  YAMAGUCHI Takenori (President Emeritus, National Cerebral and Cardiovascular Center, Suita, Osaka, JPN)
Material： Journal of Stroke & Cerebrovascular Diseases  (J Stroke Cerebrovasc Dis)
Volume： 22  Issue： 5  Page： 571-600  Publication year： Jul. 2013 
JST Material Number： W1420A  ISSN： 1052-3057  Document type： Article
Article type： 文献レビュー  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *cerebral apoplexy ,...
Semi thesaurus term： *alteplase ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A1176606&from=J-GLOBAL&jstjournalNo=W1420A") }}

JST classification (2)： Clinical application of drugs acting on blood and body fluid  (GW14020X) ,  Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Reference (171)：

• The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
• Yamaguchi T, Mori E, Minematsu K, et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial. Stroke 2006;37:1810-1815.
• Guideline Committee of the Japan Stroke Society for IV rt-PA (alteplase) in acute ischemic stroke. Guidelines for IV application of rt-PA (alteplase), October 2005 [in Japanese]. Jpn J Stroke 2005;27:327-354.
• Shinohara Y, Yanagihara T, Abe K, et al. I. Stroke in general (Guidelines for the Management of Stroke 2009). J Stroke Cerebrovasc Dis 2011;20(4 Suppl):S7-S30.
• Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.

Terms in the title (8)： 組換え ,  組織型プラスミノーゲン活性化因子 ,  アルテプラーゼ ,  静脈投与 ,  ガイドライン ,  日本 ,  脳卒中 ,  学会